Evidence map›Paper›PMID 21118570›Full record

ArticleBMC genomics2010

A genomic perspective on the potential of Actinobacillus succinogenes for industrial succinate production.

James B McKinlay, Maris Laivenieks, Bryan D Schindler, Anastasia A McKinlay, Shivakumara Siddaramappa, Jean F Challacombe, Stephen R Lowry, Alicia Clum, Alla L Lapidus, Kirk B Burkhart and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Enhanced Succinate Production inBiotech (Basel (Switzerland)) · 2025
    Article
  3. Article
  4. Microorganisms · 2025
    Article
  5. Production of Succinic Acid by Metabolically EngineeredJournal of microbiology and biotechnology · 2024
    Article
  6. Review
  7. Asuc_0142 ofMicrobiology (Reading, England) · 2023
    Article
  8. Article
  9. A Genomic Perspective on the Potential of Wild-Type Rumen BacteriumInternational journal of molecular sciences · 2020
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Complete Genome Sequence ofGenome announcements · 2018
    Article
  16. Continuous succinic acid fermentation byBiotechnology for biofuels · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

James B McKinlayDepartment of Microbiology and Molecular Genetics, 2215 Biomedical Biophysical Sciences building, Michigan State University, East Lansing, MI 48824, USA.
Maris Laivenieks
Bryan D Schindler
Anastasia A McKinlay
Shivakumara Siddaramappa
Jean F Challacombe
Stephen R Lowry
Alicia Clum
Alla L Lapidus
Kirk B Burkhart
Victoria Harkins
Claire Vieille
Michigan State University · USJoint Genome Institute · USLos Alamos National Laboratory · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSuccinate is produced petrochemically from maleic anhydride to satisfy a small specialty chemical market. If succinate could be produced fermentatively at a price competitive with that of maleic anhydride, though, it could replace maleic anhydride as the precursor of many bulk chemicals, transforming a multi-billion dollar petrochemical market into one based on renewable resources. Actinobacillus succinogenes naturally converts sugars and CO2 into high concentrations of succinic acid as part of a mixed-acid fermentation. Efforts are ongoing to maximize carbon flux to succinate to achieve an industrial process.

resultsDescribed here is the 2.3 Mb A. succinogenes genome sequence with emphasis on A. succinogenes's potential for genetic engineering, its metabolic attributes and capabilities, and its lack of pathogenicity. The genome sequence contains 1,690 DNA uptake signal sequence repeats and a nearly complete set of natural competence proteins, suggesting that A. succinogenes is capable of natural transformation. A. succinogenes lacks a complete tricarboxylic acid cycle as well as a glyoxylate pathway, and it appears to be able to transport and degrade about twenty different carbohydrates. The genomes of A. succinogenes and its closest known relative, Mannheimia succiniciproducens, were compared for the presence of known Pasteurellaceae virulence factors. Both species appear to lack the virulence traits of toxin production, sialic acid and choline incorporation into lipopolysaccharide, and utilization of hemoglobin and transferrin as iron sources. Perspectives are also given on the conservation of A. succinogenes genomic features in other sequenced Pasteurellaceae.

conclusionsBoth A. succinogenes and M. succiniciproducens genome sequences lack many of the virulence genes used by their pathogenic Pasteurellaceae relatives. The lack of pathogenicity of these two succinogens is an exciting prospect, because comparisons with pathogenic Pasteurellaceae could lead to a better understanding of Pasteurellaceae virulence. The fact that the A. succinogenes genome encodes uptake and degradation pathways for a variety of carbohydrates reflects the variety of carbohydrate substrates available in the rumen, A. succinogenes's natural habitat. It also suggests that many different carbon sources can be used as feedstock for succinate production by A. succinogenes.

Indexed as

Industrial MicrobiologyActinobacillusBacterial ProteinsBase SequenceCell MembraneGenome, BacterialIronMetabolic Networks and PathwaysMolecular Sequence DataPhylogenyProphagesRepetitive Sequences, Nucleic AcidRNA, Ribosomal, 16SSuccinic AcidVirulenceBacterial ProteinsIronRNA, Ribosomal, 16SSuccinic Acid

Identifiers

PMID21118570
PMCPMC3091790
OpenAlexW1970740144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.